Survival Advantage of Treosulfan Plus Fludarabine Before Allogeneic Hematopoietic Cell Transplantation for Older or Comorbid Patients With Myeloid Malignancies.

Aged Busulfan / analogs & derivatives Comorbidity Hematopoietic Stem Cell Transplantation Humans Middle Aged Neoplasms Transplantation Conditioning Vidarabine / analogs & derivatives
Allogeneic hematopoietic cell transplantation Busulfan Reduced intensity Reduced toxicity Treosulfan

Journal

Transplantation and cellular therapy
ISSN: 2666-6367
Titre abrégé: Transplant Cell Ther
Pays: United States
ID NLM: 101774629

Informations de publication

Date de publication:
11 2021
Historique:
received: 29 03 2021
revised: 24 06 2021
accepted: 19 07 2021
pubmed: 29 7 2021
medline: 27 1 2022
entrez: 28 7 2021
Statut: ppublish

Résumé

We have previously shown an advantage of a myeloablative conditioning regimen with reduced toxicity (Fludarabine 150 mg/m

Identifiants

DOI: 10.1016/j.jtct.2021.07.020 PMID: 34320443
pubmed: 34320443
pii: S2666-6367(21)01101-5
doi: 10.1016/j.jtct.2021.07.020
pii:
doi:

Substances chimiques

treosulfan CO61ER3EPI
Vidarabine FA2DM6879K
Busulfan G1LN9045DK
fludarabine P2K93U8740

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

916.e1-916.e6

Informations de copyright

Copyright © 2021 The American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc. All rights reserved.

Auteurs

Ioanna Sakellari (I)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Eleni Gavriilaki (E)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece. Electronic address: elenicelli@yahoo.gr.

Despina Mallouri (D)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Ioannis Batsis (I)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Christos Varelas (C)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Sofia Tagara (S)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Zoi Bousiou (Z)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Maria Papathanasiou (M)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Anna Vardi (A)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Apostolia Papalexandri (A)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Chrysanthi Vadikoliou (C)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Anastasia Athanasiadou (A)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Chrysavgi Lalayanni (C)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Asimina Fylaktou (A)

National Peripheral Histocompatibility Center, Department of Immunology, Hippokration General Hospital, Thessaloniki, Greece.

Konstantinos Antoniadis (K)

Aristotle University of Thessaloniki, School of Health Sciences, School of Dentistry, Thessaloniki, Greece.

Achilles Anagnostopoulos (A)

Hematology Department - BMT Unit, G Papanicolaou Hospital, Thessaloniki, Greece.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Survival Advantage of Treosulfan Plus...
questionsmedicales.fr › Composés chimiques organiques › Composés du soufre › Acides du soufre › Acides sulfoniques › Acides alcanesulfoniques › Alcanesulfonates › Méthanesulfonates › Busulfan › Survival Advantage of Treosulfan Plus...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Facteurs épidémiologiques › Comorbidité › Survival Advantage of Treosulfan Plus...
questionsmedicales.fr › Procédures de chirurgie opératoire › Transplantation › Transplantation cellulaire › Transplantation de cellules souches › Transplantation de cellules souches hématopoïétiques › Survival Advantage of Treosulfan Plus...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Survival Advantage of Treosulfan Plus...
questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Adulte d'âge moyen › Survival Advantage of Treosulfan Plus...
questionsmedicales.fr › Tumeurs › Survival Advantage of Treosulfan Plus...
questionsmedicales.fr › Techniques d'investigation › Techniques immunologiques › Immunosuppression thérapeutique › Conditionnement pour greffe › Survival Advantage of Treosulfan Plus...
questionsmedicales.fr › Acides nucléiques, nucléotides et nucléosides › Nucléosides › Nucléoside purique › Vidarabine › Survival Advantage of Treosulfan Plus...